About Us
We embrace the full spectrum of biofabrication technologies to innovate regenerative medicine
We stand at the intersection of engineering and biology by integrating advance biofabrication technologies with clinically driven design
We create smart and biodegradable materials that supports and accelerate tissue regeneration, bridging cutting-edge science with real-world medical needs, offering innovative solutions for chronic wounds and beyond.
Our Mission
To save limbs and transform lives by delivering breakthrough regenerative therapies that truly heal chronic wounds, especially those that today remain unresponsive to any treatment
Our Vision
To build a future where advanced biofabrication and biomaterials enable effective, accessible regenerative treatments for all—starting with chronic wounds, and expanding to restore tissues and organs impacted by injury, disease, or degeneration.
Meet the Team
We are a team of engineers, scientists, and clinicians from multidisciplinary fields, combining expertise with the solemn purpose of producing innovative regenerative therapies that restore health and improve the lives of patients suffering from chronic wounds and tissue damage.
CEO
Denise Zujur, PhD
PhD from the University of Tokyo and business studies at Globis University. Denise leads Smart Tissues’ core technology development and strategic direction. Named EY Winning Women Japan 2024 for her innovative leadership.
CTO
Ysmaldo Landaez
MSc from the University of Tokyo and hardware engineer specializing in 3D bioprinting technology. Ysmaldo leads the biofabrication of wound dressings and manufacturing scale-up.
CSO
Gustavo Rosales, PhD
Materials scientist with a PhD from the University of Tokyo. Dr. Rosales manages scientific strategy to ensure clinical relevance and innovation in our therapies.
Medical Advisor
Keisuke Miyake, MD, PhD
Vascular surgeon and assistant professor at Osaka University. Dr. Miyake brings extensive clinical expertise and leads our clinical strategy and regulatory planning efforts, ensuring that our solutions meet rigorous medical standards and align with regulatory requirements for safe and effective patient care.
Scientific Advisor
Makoto Ikeya, PhD
Associate Professor at Kyoto University’s Center for iPS Cell Research and Application (CiRA) and a recognized leader in regenerative medicine. Dr. Ikeya brings extensive expertise in stem cell biology, tissue regeneration, and translational research. He supports our scientific strategy and research initiatives, helping ensure that our technologies are built on a strong scientific foundation.
We received multiple awards in the past 5 years
